Chandra Panchal

Chandra Panchal is a declared insider of Medicenna Therapeutics Corp., with filings sourced from SEDI. In total, 6 filings cover trades dated from 1 March 2017 to 5 November 2021.

Every open-market trade on record is a purchase: 5 purchases worth €2,315, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2021: 1 purchase and no sales on the market.

In size, the median ticket on the buying side is €332. The 5 purchases reviewed show no overlap with other insiders buying the same stock within a month.

The newest entry dates from 5 November 2021: an open-market purchase of €913, in Medicenna Therapeutics Corp. Most trades are made public on the day they happen. Until a filing is published, the market cannot know about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.